March 9, 2017 / 6:19 AM / 7 months ago

BRIEF-Pharming Group FY net loss widens to 17.5 million euros

March 9 (Reuters) - Pharming Group NV:

* FY revenue from product sales 13.7 million euros ($14.43 million) versus 8.6 million euros year ago

* FY revenue 15.9 million euros versus 10.8 million euros year ago

* FY net loss 17.5 million euros versus loss of 10.0 million euros year ago

* Cash position, including restricted cash, 32.1 million euros at year-end 2016 versus 31.8 million euros at year-end 2015

* For 2017 sees continued growth in revenues from sales of RUCONEST, mainly driven by the US operations

* For 2017 sees achievement of positive quarterly operating results in the course of the year Source text for Eikon: Further company coverage: ($1 = 0.9497 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below